Moschner Matthew 4
4 · COGNEX CORP · Filed Feb 24, 2026
Research Summary
AI-generated summary of this filing
Cognex (CGNX) CEO Matthew Moschner Receives RSUs; Shares Withheld
What Happened
Matthew Moschner, CEO, President and a director of Cognex (CGNX), had restricted stock units (RSUs) vest on Feb 20–21, 2026. A total of 6,537 RSUs converted into the same number of shares (exercise/conversion at $0.00 per share). To satisfy tax withholding obligations, 1,919 shares were withheld and reported as dispositions at $56.03 per share (total withheld value ≈ $107,522), leaving a net receipt of 4,618 shares (value of retained shares ≈ $258,747 using $56.03/share).
Key Details
- Transaction dates: Feb 20, 2026 and Feb 21, 2026.
- Conversion/exercise price: $0.00 (these were RSUs converting to shares).
- Tax-withheld dispositions: 893 shares @ $56.03 = $50,035 and 1,026 shares @ $56.03 = $57,487 (total ≈ $107,522).
- Total RSUs vested/converted: 6,537 shares; net shares received after withholding: 4,618.
- Footnotes: F1–F2 confirm the withheld shares satisfy tax withholding on the RSUs vesting on Feb 20 and Feb 21; F3 clarifies each RSU equals one share; F4–F5 show the RSU vesting schedules from grants dated Feb 21, 2023 and Feb 20, 2024 (20%/30%/50% annual tranches).
- Filing timeliness: Report filed Feb 24, 2026 (timely within the two-business-day requirement for transactions on Feb 20–21).
Context
These entries reflect RSU vesting and the standard “share withholding” to cover tax obligations, not an open-market sell for cash. The $0 exercise price and the footnotes identify the instruments as RSUs (not option purchases). Such withholding is routine and does not necessarily indicate a change in the insider’s view of the company.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-20+3,042→ 14,889 total - Tax Payment
Common Stock
[F1]2026-02-20$56.03/sh−893$50,035→ 13,996 total - Exercise/Conversion
Common Stock
2026-02-21+3,495→ 17,491 total - Tax Payment
Common Stock
[F2]2026-02-21$56.03/sh−1,026$57,487→ 16,465 total - Exercise/Conversion
Restricted Stock Unit
[F3][F4]2026-02-21−3,495→ 0 totalExercise: $0.00From: 2024-02-21Exp: 2026-02-21→ Common Stock (3,495 underlying) - Exercise/Conversion
Restricted Stock Unit
[F3][F5]2026-02-20−3,042→ 5,071 totalExercise: $0.00From: 2025-02-20Exp: 2027-02-20→ Common Stock (3,042 underlying)
- 279,070
Non-Qualified Stock Option (right to buy)
Exercise: $27.99From: 2029-05-05Exp: 2035-05-05→ Common Stock (279,070 underlying) - 76,924
Non-Qualified Stock Option (right to buy)
Exercise: $32.78From: 2029-02-21Exp: 2035-02-21→ Common Stock (76,924 underlying) - 68,823
Non-Qualified Stock Option (right to buy)
Exercise: $33.04From: 2026-02-18Exp: 2035-02-18→ Common Stock (68,823 underlying) - 58,260
Non-Qualified Stock Option (right to buy)
Exercise: $39.44From: 2025-02-20Exp: 2034-02-20→ Common Stock (58,260 underlying) - 4,000
Non-Qualified Stock Option (right to buy)
Exercise: $40.71From: 2019-11-19Exp: 2028-11-19→ Common Stock (4,000 underlying) - 7,000
Non-Qualified Stock Option (right to buy)
Exercise: $42.84From: 2021-10-31Exp: 2028-10-31→ Common Stock (7,000 underlying) - 37,832
Non-Qualified Stock Option (right to buy)
Exercise: $47.21From: 2024-02-21Exp: 2033-02-21→ Common Stock (37,832 underlying) - 35,639
Non-Qualified Stock Option (right to buy)
Exercise: $47.95From: 2026-08-04Exp: 2032-08-04→ Common Stock (35,639 underlying) - 47,962
Non-Qualified Stock Option (right to buy)
Exercise: $50.01From: 2027-08-07Exp: 2033-08-07→ Common Stock (47,962 underlying) - 4,000
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (4,000 underlying) - 9,000
Non-Qualified Stock Option (right to buy)
Exercise: $51.97From: 2020-10-30Exp: 2029-10-30→ Common Stock (9,000 underlying) - 1,600
Non-Qualified Stock Option (right to buy)
Exercise: $56.44From: 2019-02-20Exp: 2028-02-20→ Common Stock (1,600 underlying) - 58,744
Non-Qualified Stock Option (right to buy)
Exercise: $57.09From: 2027-02-17Exp: 2036-02-17→ Common Stock (58,744 underlying) - 8,426
Non-Qualified Stock Option (right to buy)
Exercise: $86.38From: 2025-08-09Exp: 2031-08-09→ Common Stock (8,426 underlying) - 4,999
Restricted Stock Unit
Exercise: $0.00From: 2024-08-07Exp: 2026-08-07→ Common Stock (4,999 underlying) - 20,339
Restricted Stock Unit
Exercise: $0.00From: 2026-02-18Exp: 2028-02-18→ Common Stock (20,339 underlying) - 56,928
Restricted Stock Unit
Exercise: $0.00From: 2027-02-17Exp: 2029-02-17→ Common Stock (56,928 underlying)
Footnotes (5)
- [F1]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein.
- [F2]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
- [F4]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
- [F5]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.